Clostridium

Department of Health written question – answered on 26th May 2016.

Alert me about debates like this

Photo of Lord Hunt of Kings Heath Lord Hunt of Kings Heath Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords

To ask Her Majesty’s Government what assessment they have made of the outcome and cost effectiveness of the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.

Photo of Lord Hunt of Kings Heath Lord Hunt of Kings Heath Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords

To ask Her Majesty’s Government what assessment they have made of the rate of uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.

Photo of Lord Prior of Brampton Lord Prior of Brampton The Parliamentary Under-Secretary of State, Department of Health

The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent Clostridium difficile infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.

Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile is not collected centrally.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.